US revokes citizenship of couple convicted of stealing medical trade secrets for China
A United States federal court has revoked the citizenship of a naturalised couple originally from China following their conviction for stealing sensitive medical trade secrets and sharing them for unauthorized use. The ruling marks a significant legal development in cases involving intellectual property theft and national security concerns. Authorities said the decision reflects the seriousness of the offenses and reinforces the principle that citizenship can be withdrawn if it is obtained or maintained under conditions that violate legal and ethical standards required under US law.
The case centers on Li Chen and Yu Zhou, who were previously convicted on charges including conspiracy to commit trade secret theft and wire fraud. Court records show the couple admitted to obtaining confidential medical technology and using it for personal financial gain while also benefiting external entities. A federal judge determined that their actions demonstrated a failure to meet the “good moral character” requirement necessary for maintaining naturalised citizenship, leading to the decision to revoke their status.
Officials emphasized that the ruling aligns with broader enforcement efforts aimed at protecting sensitive technologies and preventing unauthorized transfer of intellectual property. Cases involving the theft of scientific and medical research have become a growing concern as global competition in advanced industries intensifies. Authorities have increasingly taken a stricter approach toward violations that involve cross border elements, particularly when critical technologies are involved.
The decision also highlights the legal framework governing naturalisation in the United States, where citizenship can be rescinded if individuals are found to have engaged in serious criminal conduct that undermines eligibility requirements. Legal experts note that such cases remain relatively rare but serve as a strong deterrent against misuse of access to sensitive information. The enforcement of these rules reflects ongoing efforts to safeguard innovation, research integrity and national security interests.
The case comes amid heightened scrutiny of intellectual property protection and technology transfer in the context of global competition. Governments and institutions are placing greater emphasis on securing research environments and monitoring potential risks associated with data access and collaboration. As technological development accelerates, ensuring the protection of proprietary knowledge remains a key priority for policymakers and industry leaders alike.
